Your session is about to expire
← Back to Search
Prostate Cancer Screening Education for Prostate Cancer
N/A
Recruiting
Led By Erika Trapl, PhD
Research Sponsored by Case Comprehensive Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at 14 months
Awards & highlights
Study Summary
This trial is testing ways to get more Black or African American men over 40 to get screened for prostate cancer, specifically through a prostate-specific antigen (PSA) test.
Who is the study for?
This trial is for Black or African American individuals who are 40 years old or older, have a prostate gland, and haven't had a PSA test in the last year. They must be able to consent to the study and speak English. Those who've had their prostate removed can't join.Check my eligibility
What is being tested?
The study tests different ways of educating about prostate cancer screening: one-on-one guidance from community navigators, education at community events, and passive educational materials. The goal is to see if these methods increase PSA testing rates.See study design
What are the potential side effects?
Since this trial focuses on educational interventions rather than medical treatments, there are no direct side effects related to medication or procedures. However, participants may experience anxiety or stress related to learning about cancer risks.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ at 14 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at 14 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Secondary outcome measures
PSA Screening Test
Primary Care Physician Visit
Trial Design
3Treatment groups
Experimental Treatment
Group I: Education and Passive NavigationExperimental Treatment1 Intervention
This arm receives barber-led education and access to a resource website. Barbers will encourage clients to access the screening website. Other study materials will also be located within the shop. The resource website will be accessible via QR code that will encourage potential participants to complete a Prostate Cancer Knowledge and Risk Assessment questionnaire.
Group II: Education and Active Navigation with Community Based OutreachExperimental Treatment3 Interventions
This arm adds the community navigator and a community outreach screening event. Case Comprehensive Cancer Center Community Outreach and Engagement will offer barber shops an onsite PSA screening event.
Group III: Education and Active NavigationExperimental Treatment2 Interventions
This arm includes all interventions of the first arm plus the addition of a community navigator. The community navigator will be onsite to assist in information delivery and navigation to resources and encourage the completion of the Screener through the QR code. The community navigator will help participants connect with a primary care provider to continue with all preventive healthcare recommendations.
Find a Location
Who is running the clinical trial?
Case Comprehensive Cancer CenterLead Sponsor
452 Previous Clinical Trials
31,110 Total Patients Enrolled
31 Trials studying Prostate Cancer
2,313 Patients Enrolled for Prostate Cancer
Erika Trapl, PhDPrincipal InvestigatorCase Comprehensive Cancer Center
1 Previous Clinical Trials
658 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have had surgery to remove my prostate.I have never had a PSA test or it's been over a year since my last one.I am 40 years old or older.I have a prostate gland.
Research Study Groups:
This trial has the following groups:- Group 1: Education and Passive Navigation
- Group 2: Education and Active Navigation
- Group 3: Education and Active Navigation with Community Based Outreach
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are participants still able to enlist in this clinical trial?
"Sadly, clinicaltrials.gov has indicated that this medical study is no longer seeking participants since its last updated on November 3rd 2022. However, there are still 1,321 other studies actively recruiting patients at present."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger